Surveying The Outcomes Of Lubiprostone (The STOOL Study) in Nursing Home Residents
Withdrawn before enrolling
Conditions studied: Constipation
In brief
The purpose is to assess the efficacy, clinical outcomes, and potential Quality Indicator benefits associated with the use of Lubiprostone in nursing home residents with a confirmed diagnosis of chronic idiopathic constipation.
Key facts
- Study ID
- NCT00985569
- Run by
- Synergy Health Solutions
- People needed
- 105
- Starts
- 2009-11-01
- Expected to finish
- 2010-11-01
- Last updated by the study team
- 2010-11-23
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients must meet all of the following criteria to be eligible for the study:
- Adult men and women nursing home residents;
- Confirmed diagnosis of CIC using Rome criteria;
- Prescribed two or more laxatives, at recruitment;
- Taking 9 or more oral medicines (including prescription, OTC and prn)
- Free from conditions likely to be fatal within six months;
- Able to read or understand English; and
- Able and willing to provide informed consent or has a guardian/agent who can provide consent.
You may not qualify if…
- Currently pregnant;
- Presence of megacolon;
- Presence of rectal sigmoid cancer;
- Presence of colon cancer;
- Presence of anal incompetence;
- Conditions likely to be fatal within six months;
- Taking 8 or fewer medicines;
- Enrolled in hospice;
- Non-English speaking patients; and
- Unwilling or unable to provide informed consent and has no guardian/agent.
- Expected to be discharged within 3 months.
Where it is running
- Geriatric Medical Associates — Brooksville, Florida, United States
- Cassellberry Family Practice — Casselberry, Florida, United States
- Osler Geriatrics — Melbourne, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.